PharmaVoice
1,318 FOLLOWERS
PharmaVoice offers multiple channels for brand enhancement, thought-leadership positioning, and lead generation to the pharma, biotech, and med device industry.
PharmaVoice
2d ago
While the H5N1 threat to humans is still low, the recent influenza outbreak in cattle is presenting strange and challenging hurdles for containment ..read more
PharmaVoice
2d ago
The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing ..read more
PharmaVoice
3d ago
Execs from J&J, Novartis, Novo Nordisk and AbbVie sound off on the Inflation Reduction Act, supply issues and launch preparations in a tricky environment ..read more
PharmaVoice
4d ago
After missing analysts’ earnings expectations for Mounjaro sales in the first quarter due to overwhelming demand, Lilly is also dealing with a legal loss and incoming pricing questions from lawmakers ..read more
PharmaVoice
5d ago
The old guard of pharma bestsellers is seeing more competition, but newer drugs demonstrating sales and revenue growth can build up the coffers in years to come ..read more
PharmaVoice
6d ago
As commercial momentum builds, coverage incentives for the Medicare market are expected to favor biosimilars in 2025 ..read more
PharmaVoice
6d ago
SmartLabs offers the first integrated platform combining re-configurable lab infrastructure, operations and scientific expertise ..read more
PharmaVoice
1w ago
The CEO of Daiichi Sankyo’s American business explains why it could be poised to become a “top 10” cancer company ..read more
PharmaVoice
1w ago
The recent SCOTUS case involving mifepristone exposes the risk of drug safety determinations by judicial fiat ..read more